Rivaroxaban May Be Clinically Superior to LMWH in Patients With Cancer-Associated Thrombosis
Researchers sought to determine whether rivaroxaban may be superior to low-molecular-weight heparin for reducing all-cause mortality.
Researchers sought to determine whether rivaroxaban may be superior to low-molecular-weight heparin for reducing all-cause mortality.
Researchers sought to determine whether MRD status could be a helpful prognostic tool for survival in patients with acute leukemia prior to allo-HSCT.
Researchers conducted 2 sets of literature reviews to determine whether the professional society recommendations for >50% factor levels during labor in patients with hemophilia was accurate.
Researchers sought to determine whether cfDNA is not only a marker of, but makes a contribution to, pathophysiology of sickle cell disease.
Researchers reviewed patient samples to determine whether NGS of cell-free DNA may help in treatment decision-making for patients with hematologic malignancies who may have an infection.
Researchers sought to determine whether idecabtagene vicleucel, a CAR-T cell therapy, would be a viable treatment option in heavily pretreated patients with relapsed or refractory multiple myeloma.
Researchers sought to determine whether patients with ITP treated with eltrombopag would have SROT.
Researchers sought to determine whether deferiprone could be a good option to treat pediatric patients with transfusion-dependent hemoglobinopathy.
Researchers sought to determine whether physiotherapy and exercise would be an effective therapy for increasing functionality, joint health, and quality of life in patients with hemophilic arthropathy of the elbow.
Hemoglobin levels, platelet counts, creatinine levels, and ADAMTS13 activity were all significantly higher in the general TMA group.